Buscar
Mostrando ítems 1-10 de 64
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2011-12-01)
BACKGROUND: The detection of molecular and cytogenetic alterations is important for the diagnosis, prognosis and classification of myeloproliferative neoplasms. OBJECTIVE: The aim of this study was to detect the following ...
JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
(Sociedade Brasileira de Genética, 2007)
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
(BMC (BioMed Central)Hematopatologia MolecularSalud y SostenibilidadLondres, Inglaterra, 2022)
Diagnosis and treatment of polycythemia vera: Brazilian experience from a single institution
(Associação Paulista de Medicina - APM, 2008)
CONTEXT AND OBJECTIVE: Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by predominant proliferation of erythroid precursors. Few data are available concerning Brazilian patients with this ...
A mutação JAK2 V617F e as síndromes mieloproliferativasJAK2 V617F mutation and the myeloproliferative disorders
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
Philadelphia-negative chronic myeloproliferative neoplasms
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2012-01-01)
Chronic myeloproliferative diseases without the Philadelphia chromosome marker (Ph-), although first described 60 years ago, only became the subject of interest after the turn of the millennium. In 2001, the World Health ...
Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms
(Taylor & francis ltd, 2016)
Philadelphia-negative chronic myeloproliferative neoplasms
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2012)
Análises de mutações no gene JAK2 em pacientes com diagnóstico clínico de Policitemia Vera atendidos em um único centro da cidade de Juiz de Fora
(Universidade Federal de Juiz de ForaBrasilICB – Instituto de Ciências BiológicasPrograma de Pós-graduação em Ciências Biológicas: Imunologia e Doenças Infecto-Parasitárias/Genética e BiotecnologiaUFJF, 2016)